Journal list Promote Sponsor
verified SJR 0,214 · Q3 • database Scopus / SJR & DOAJ indexed
Case Report in Veterinary Medicine
Egypt · John Wiley and Sons Ltd
workspace_premium Q3 — Veterinary (miscellaneous) verified Plan S Compliant visibility_off Single blind Peer Review lock_open Open Access · DOAJ

Case Report in Veterinary Medicine

Case Report in Veterinary Medicine is a journal indexed in SJR in Veterinary (miscellaneous) with an H index of 10. It is an CC BY Journal with a Single blind Peer Review review system, and It has a price of 517.5 €. The scope of the journal is focused on veterinary medicine. It has an SJR impact factor of 0,214 and it has a best quartile of Q3. It is published in English. It has an SJR impact factor of 0,214.

ISSN: 2090-7001
Publisher: John Wiley and Sons Ltd
Category: Veterinary (miscellaneous)
Indexation: verifiedScopus / SJR verifiedDOAJ
open_in_new Portal NPD menu_book Author guidelines
schedule CountryOfPapers database fields
SJR Impact Factor trending_up
0,214 Q3
H-index 10
Acceptance rate pie_chart
59%
Source Acceptance_Rate
Time to publication hourglass_top
13 weeks
Field Average_time_publication_weeks
Publication cost (APC) payments
518 € Open Access
Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR DOAJ

SJR Impact

0,214

H-index

10

Docs (year)

8

Docs 3y

45

Total refs

190

Cites 3y

20

Citable 3y

45

Cites/Doc 2y

0.44

Ref/Doc

23.75

Immediate OA

517.5 €

Embargoed OA

NPD

Non OA / Submission

- €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims
rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.
User
* Only to validate authenticity — identity is not shown publicly.

FAQs